Vasculopathy related to manic/hypomanic symptom burden and first-generation antipsychotics in a sub-sample from the collaborative depression study

Keyphrases

• Depression Study 100%
• Vasculopathy 100%
• Symptom Burden 100%
• Second-generation Antipsychotics 100%
• Hypomanic Symptoms 100%
• Mood Disorders 75%
• Vascular Function 50%
• Metabolic Function 50%
• Augmentation Pressure 50%
• Dyslipidemia 25%
• Insulin Resistance 25%
• Non-associated 25%
• Depressive Symptoms 25%
• Cardiovascular Risk 25%
• Systolic Blood Pressure 25%
• Brachial 25%
• Systolic Pressure 25%
• Dose Effect 25%
• Low Flow 25%
• University of Washington 25%
• Vascular Disease 25%
• Dose-response Relationship 25%
• Antipsychotics 25%
• Multivariate Linear Regression 25%
• National Institute of Mental Health 25%
• Treatment Course 25%
• Elevated Blood Pressure 25%
• University of Iowa 25%
• Function Evaluation 25%
• Endothelial Function 25%
• Course of Illness 25%
• Phenotypic Methods 25%
• Mood Stabilizers 25%
• Arterial Stiffness 25%
• Iowa 25%
• Cumulative Exposure 25%
• Functioning Assessment 25%
• Mood Symptoms 25%
• Flow-mediated Dilation 25%
• Hypomanic 25%

Medicine and Dentistry

• Vascular Disease 100%
• Mood Disorder 60%
• Systolic Blood Pressure 40%
• Antipsychotic 40%
• Mental Health 20%
• Insulin Resistance 20%
• Cardiovascular Disease 20%
• Arterial Stiffness 20%
• Linear Regression Analysis 20%
• Dyslipidemia 20%
• Elevated Blood Pressure 20%
• Chronicity 20%
• Endothelial Function 20%
• Mood Stabilizer 20%
• Diseases 20%
• Depressive Disorder 20%

Neuroscience

• Vascular Disease 100%
• Mood Disorder 60%
• Antipsychotic 40%
• Dyslipidemia 20%
• Mood Stabilizer 20%
• Depressive Disorder 20%